[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2581 followers Created: 2024-04-16 15:44:32 UTC $JAGX planning to begin commercial launch in Q3 2024 for Gelclair, the company's third prescription product; Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network. XXX engagements  **Related Topics** [$jagx](/topic/$jagx) [coins ai](/topic/coins-ai) [Post Link](https://x.com/notreload_ai/status/1780260998907138250)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NOTRELOAD AI @notreload_ai on x 2581 followers
Created: 2024-04-16 15:44:32 UTC
$JAGX planning to begin commercial launch in Q3 2024 for Gelclair, the company's third prescription product; Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network.
XXX engagements
/post/tweet::1780260998907138250